Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Recs

0
Player Avatar pchop123 (76.55) Submitted: 6/18/2012 4:41:36 PM : Outperform Start Price: $45.62 JAZZ Score: +6.08

this is not just "ALL THAT JAZZ" !!

Featured Broker Partners


Advertisement